Top

Reactions Weekly

Published in:

01-08-2023 | Mepolizumab | Case report

Mepolizumab/prednisolone

Psoriasis vulgaris and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Yokota N, et al. Psoriasis-like skin rash triggered by a local infection in a patient with eosinophilic granulomatosis with polyangiitis that was well controlled by mepolizumab treatment. Clinical Case Reports 11: No. 6, Jun 2023. Available from: URL: http://dx.doi.org/10.1002/ccr3.7532

Title: Mepolizumab/prednisolone
Psoriasis vulgaris and lack of efficacy: case report
Publication date: 01-08-2023
Publisher: Springer International Publishing
Keywords: Mepolizumab
Churg-Strauss Syndrome
Churg-Strauss Syndrome
Vulgar Psoriasis
Omalizumab
Prednisolone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-44359-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mepolizumab/prednisolone

Psoriasis vulgaris and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Antineoplastics

Ibrutinib

Multiple drugs

Antiepileptic drugs

Spirulina